To Assess the Efficacy and Safety of Dual Anticoagulants i.e. Rivaroxaban Plus Aspirin and Clopidogrel Plus Aspirin in Patients Suffering From an Acute Coronary Syndrome
Clinical trial NCT05573958 · UNKNOWN
Trial details
- NCT number
- NCT05573958
- Sponsor
- Sarmad Zahoor
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-01
- Primary completion
- 2023-03-31
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.